These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
562 related items for PubMed ID: 11753882
1. Papillary serous carcinoma of peritoneum: case study and review of the literature on the differential diagnosis of malignant peritoneal tumors. Koutselini HA, Lazaris AC, Thomopoulou G, Papayannopoulou A, Kairi-Vasilatou E. Adv Clin Path; 2001 Jul; 5(3):99-104. PubMed ID: 11753882 [Abstract] [Full Text] [Related]
8. Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas. Ordóñez NG. Am J Surg Pathol; 1998 Oct; 22(10):1203-14. PubMed ID: 9777982 [Abstract] [Full Text] [Related]
9. Value of estrogen and progesterone receptor immunostaining in distinguishing between peritoneal mesotheliomas and serous carcinomas. Ordóñez NG. Hum Pathol; 2005 Nov; 36(11):1163-7. PubMed ID: 16260268 [Abstract] [Full Text] [Related]
10. [Correlation between serious ovarian tumors and extra-ovarian peritoneal tumors of the same histology]. Kunz J, Rondez R. Praxis (Bern 1994); 1998 Feb 04; 87(6):191-8. PubMed ID: 9531813 [Abstract] [Full Text] [Related]
11. Immunohistochemical analysis of peritoneal mesothelioma and primary and secondary serous carcinoma of the peritoneum: antibodies to estrogen and progesterone receptors are useful. Barnetson RJ, Burnett RA, Downie I, Harper CM, Roberts F. Am J Clin Pathol; 2006 Jan 04; 125(1):67-76. PubMed ID: 16482993 [Abstract] [Full Text] [Related]
14. Primary papillary serous carcinoma of the peritoneum: report of a case with diagnosis by fine needle aspiration and immunocytochemistry. Alberti N, Serrano-Egea A, García-García E, Ballestín C, Pérez-Barrios A, López-Ríos F, de Agustín P. Acta Cytol; 2007 Jan 04; 51(2):203-6. PubMed ID: 17425204 [Abstract] [Full Text] [Related]
15. [Serous papillary cancer of the peritoneum: a multicentric primary disease]. Maassen V, Debus-Thiede G. Zentralbl Gynakol; 1993 Jan 04; 115(8):347-54. PubMed ID: 8212940 [Abstract] [Full Text] [Related]
16. Value of immunohistochemistry in distinguishing peritoneal mesothelioma from serous carcinoma of the ovary and peritoneum: a review and update. Ordóñez NG. Adv Anat Pathol; 2006 Jan 04; 13(1):16-25. PubMed ID: 16462153 [Abstract] [Full Text] [Related]
17. Primary peritoneal serous papillary carcinoma: clinical and laboratory characteristics. Iavazzo C, Vorgias G, Katsoulis M, Kalinoglou N, Dertimas V, Akrivos T. Arch Gynecol Obstet; 2008 Jul 04; 278(1):53-6. PubMed ID: 18488238 [Abstract] [Full Text] [Related]
20. [Well-differentiated papillary mesothelioma of the peritoneum: an attenuated malignant tumor. Review of the literature apropos of a case]. Bouvier S, Baron O, Nomballais F, Guillard Y, Drianno JC, Maugard-Louboutin C, Le Mevel B, De Lajartre AY, Michaud JL. Bull Cancer; 1994 Feb 04; 81(2):104-7. PubMed ID: 7894114 [Abstract] [Full Text] [Related] Page: [Next] [New Search]